If you or someone you love has colorectal cancer, you know the hardest part isn't just the diagnosis — it's the waiting. Waiting for new treatments that take too long. Waiting for something better. Today at the Annual Meeting of the American Society of Clinical Oncology, we're letting everyone know we're going to fix that. The Colorectal Cancer Alliance is unveiling KLEOS — a bold new initiative to transform how colorectal cancer treatments are developed and approved. Backed by nearly $7.5 million in seed donations and a collaboration with the Global Coalition for Adaptive Research, KLEOS will create a smarter, faster way to test new cancer therapies. Here's what that means for patients: ✅ More treatment options, developed faster ✅ Less time lost on drugs that don't work ✅ A future where a colorectal cancer diagnosis comes with better answers We're building this now. The first patients are expected to enroll in early 2027, and the treatments that follow will change what it means to be diagnosed with colorectal cancer. KLEOS is named after the ancient Greek word for glory — for the legacy of everyone we've lost to this disease. It exists because of donors, researchers, and patients who refused to accept the status quo. Learn more 👉 bit.ly/KLEOS-Announcement If you need support right now, including help navigating clinical trials that exist today, our cancer care team is here for you. Call us at (877) 422-2030.